Illustration of bone graft filling intrabony defect.

Intrabony Defects: Can Bone Grafts Fill the Gap?

Nico Varela monogram
Nico Varela in Health & Wellness October 2026 • 3 min read.

"A closer look at how adjunctive therapies with demineralized freeze-dried bone allografts (DFDBA) enhance bone regeneration in periodontal intrabony defects."


Periodontal disease often leads to the formation of intrabony defects, which are essentially hollow spaces in the bone surrounding your teeth. Imagine the foundation of a house crumbling away—that’s similar to what happens in your mouth. These defects not only compromise the stability of your teeth but can also lead to more severe oral health issues if left unaddressed.

The primary goal of periodontal therapy has always been to restore what's lost, aiming to regenerate the tissues that support your teeth, including the periodontal ligament, alveolar bone, and cementum. This regeneration is key to regaining full functionality and preventing further deterioration.

Demineralized Freeze-Dried Bone Allograft (DFDBA) is the use of bone grafts derived from a tissue bank, processed to remove the mineral content and freeze-dried for preservation. These grafts act as a scaffold, encouraging new bone growth and helping to fill those troublesome intrabony defects. In some cases, additional materials known as adjuncts are used alongside DFDBA to boost its effectiveness.

AI Search Multiple angles on this topic

Unrelated Data Sources

The listed sources do not provide statistics about intrabony defects or bone grafts. ThatsThem describes a reverse email lookup that searches hundreds of millions of emails for associated names, addresses, and phone numbers. Wiara.pl reports 40,612 followers, while Mailmeteor describes an email checker running more than 15 verification checks.

Conflicting Market Listings

The listed sources concern Samsung C&T Corp rather than accepted methods for treating intrabony defects. AlphaSquare reports a current price of 345,000 won, while Investing.com reports that Samsung C&T closed at 346,000 won. MONEYLAND reports that 10 recent analyst reports had an average target price of 537,000 won as of September 23, 2026.

Software Help and Downloads

The listed sources do not document the history or foundational discoveries of bone grafting. YouTube Help and YouTube TV Help are official help centers offering tips, tutorials, and answers to frequently asked questions. Both OBS sources identify OBS Studio as downloadable for Windows, Mac, or Linux.

What Adjuncts Can Enhance DFDBA Treatment?

Illustration of bone graft filling intrabony defect.

Several adjuncts have shown promise in enhancing the regenerative effects of DFDBA, including:

A systematic review aimed to evaluate the effectiveness of these adjuncts when combined with DFDBA in treating intrabony defects. The review focused on clinical outcomes such as clinical attachment level gain, pocket depth reduction, and radiological bone fill.

  • Platelet-Rich Plasma (PRP): Concentrated platelets from your own blood, rich in growth factors that promote tissue repair and regeneration.
  • Enamel Matrix Derivative (EMD): Proteins that mimic the natural enamel formation process, stimulating the regeneration of periodontal tissues.
  • Cyclosporine A (CsA): An immunosuppressant drug that, in some studies, has shown potential in promoting bone formation when combined with DFDBA.
AI Search Multiple angles on this topic

Evidence Heterogeneity

The PubMed search snippet reports that three randomized controlled trials involving 79 patients and 98 intrabony defects were selected for analysis. It found significant statistical heterogeneity for probing-depth reduction, with I(2) = 85.28% and p = 0.001, and recession increase, with I(2) = 73.95% and p = 0.022. Heterogeneity was not statistically significant for clinical attachment-level gain, where I(2) = 59.30% and p = 0.086.

The study looked at randomized controlled trials (RCTs) that met specific criteria. These trials compared the use of DFDBA alone versus DFDBA in combination with adjuncts in treating periodontal intrabony defects. Clinical attachment level gain was the primary outcome, while pocket depth reduction and radiological bone fill were secondary outcomes.

Long-Term Outlook

While the current evidence suggests that certain adjuncts can indeed enhance the effectiveness of DFDBA in treating intrabony defects, it’s important to recognize that long-term studies are still needed. The sustained benefits and potential risks associated with these combined therapies require thorough investigation to refine treatment protocols and ensure optimal patient outcomes.

AI Search Multiple angles on this topic

Japan Time Resources

The listed sources address current time in Japan rather than expert commentary on intrabony defects or bone grafts. They describe live or exact Japan time, including the JST (UTC+9) time zone. The Tokyo page also covers weather, area codes, daylight-saving information, sunrise, sunset, moonrise, and moonset.

How DFDBA combinations compare with alternatives

  • 1.5 mmCompared with open-flap debridement (OFD), membrane plus a bone-derived graft produced 1.5 mm more clinical attachment-level gain, a 90% improvement relative to OFD.[1]
  • 0.67 mmFor studies with at least 12 months of follow-up, enamel matrix derivative (EMD) plus bone graft yielded 0.67 mm more attachment-level gain than bone graft alone.[2]
  • 0.88 mmA subgroup comparison found a 0.88 mm attachment-level difference for EMD combined with alloplastic grafts versus EMD alone.[3]

What the comparisons suggest-and what they cannot establish

Across these comparisons, adding a regenerative component sometimes improved measured clinical or radiographic outcomes, but the size and consistency of the benefit depended on which materials and outcomes were compared. These results do not establish that every combination is better than its comparator.[1] [2] [3] [4] [5]

A radiographic fill measurement can include graft material that remains in the defect, so an apparent improvement in fill does not necessarily establish how much new supporting tissue formed.[6] [7]

How these results fit broader comparisons

A network meta-analysis across randomized trials ranked open-flap debridement as least efficacious; regenerative or reconstructive approaches more often produced shallower residual pockets and greater attachment gain, with combination approaches appearing most effective.[8]

That broader pattern is not uniform: pooled estimates for EMD plus graft versus EMD alone showed only a slight attachment-gain difference, with an interval that included no difference.[3]

A separate comparison reported maintained clinical and radiographic improvements over time, but found no statistically significant attachment-level difference between groups; radiographic fill favored graft, with the caveat that graft material was not subtracted from the measurement.[6]

What remains unresolved about regeneration

  • How much of the measured clinical improvement represents true periodontal regeneration, rather than a change in clinical measurements or radiographic appearance? Robust evidence linking reported improvement to actual regeneration remains lacking.[7]
  • How do defect characteristics and differences among treatment combinations affect confidence in the results? Confidence in network estimates for attachment gain, pocket-depth reduction, and radiographic bone gain was rated low to very low.[9]

Terms used in the comparisons

Barrier membrane
A barrier used to maintain defect space for tissue regeneration and to stabilize, contain, and preserve graft material when used with a bone graft.[10]

Sources

  1. Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline (pmc.ncbi.nlm.nih.gov)
  2. Combination of Enamel Matrix Derivatives with Bone Graft vs Bone Graft Alone in the Treatment of Periodontal Intrabony and Furcation Defects: A Systematic Review and Meta-Analysis (pmc.ncbi.nlm.nih.gov)
  3. Enamel matrix derivative monotherapy versus combination therapy with bone grafts for periodontal intrabony defects: An updated review (pmc.ncbi.nlm.nih.gov)
  4. Efficacy of platelet rich fibrin in the treatment of human intrabony defects with or without bone graft: A randomized controlled trial (pmc.ncbi.nlm.nih.gov)
  5. NexGen regen? Challenges and opportunities for growth factors and signaling agents in periodontal regeneration at intrabony defects (pmc.ncbi.nlm.nih.gov)
  6. From Basic Science to Clinical Practice: A Review of Current Periodontal/Mucogingival Regenerative Biomaterials (pmc.ncbi.nlm.nih.gov)
  7. Biomaterials for promoting periodontal regeneration in human intrabony defects: a systematic review. (pubmed.ncbi.nlm.nih.gov)
  8. Medium‐ and long‐term clinical benefits of periodontal regenerative/reconstructive procedures in intrabony defects: Systematic review and network meta‐analysis of randomized controlled clinical studie (pmc.ncbi.nlm.nih.gov)
  9. Influence of alloplastic materials, biologics, and their combinations, along with defect characteristics, on short-term intrabony defect surgical treatment outcomes: a systematic review and network me (pmc.ncbi.nlm.nih.gov)
  10. Natural graft tissues and synthetic biomaterials for periodontal and alveolar bone reconstructive applications: a review (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What exactly are intrabony defects?

Intrabony defects are essentially hollow areas that form in the bone surrounding teeth due to periodontal disease. These defects weaken the support for the teeth, similar to a house's foundation crumbling, potentially leading to tooth instability and further oral health problems if they are not addressed. They are significant because they directly impact the structural integrity of the teeth and the overall health of the periodontium. The implications include tooth loss and the potential for more severe periodontal issues.

2

What is Demineralized Freeze-Dried Bone Allograft (DFDBA), and why is it used?

Demineralized Freeze-Dried Bone Allograft (DFDBA) involves using bone grafts sourced from a tissue bank, processed to remove mineral content, and then freeze-dried for preservation. DFDBA is significant because it acts as a scaffold to encourage new bone growth within intrabony defects. This process aids in filling the void left by the defect and restoring the support for the teeth. However, DFDBA's effectiveness can vary, and it is sometimes used in conjunction with adjuncts to enhance bone regeneration.

3

What are adjuncts, and why are they used with DFDBA?

Adjuncts, such as Platelet-Rich Plasma (PRP), Enamel Matrix Derivative (EMD), and Cyclosporine A (CsA), are used alongside Demineralized Freeze-Dried Bone Allograft (DFDBA) to boost its effectiveness in treating intrabony defects. Platelet-Rich Plasma (PRP) uses concentrated platelets from the patient's blood, rich in growth factors that stimulate tissue repair. Enamel Matrix Derivative (EMD) contains proteins that mimic the natural enamel formation process. Cyclosporine A (CsA) is an immunosuppressant that, in some studies, shows potential in promoting bone formation. These adjuncts aim to enhance the regenerative effects of DFDBA, leading to better clinical outcomes.

4

How is the success of intrabony defect treatments measured?

Clinical attachment level gain, pocket depth reduction, and radiological bone fill are all ways to measure the success of treatments for intrabony defects. Clinical attachment level gain refers to the restoration of the attachment between the gum and tooth. Pocket depth reduction indicates the decrease in the space between the tooth and gum, reducing the area where bacteria can accumulate. Radiological bone fill is the extent to which new bone has grown in the defect, visible through X-rays. These outcomes are crucial because they provide quantifiable data on the improvement of periodontal health and the regeneration of lost tissues. Success is defined by improvements to all three measures.

5

What is the long-term outlook for treating intrabony defects with DFDBA and adjuncts?

While current evidence suggests that using adjuncts with Demineralized Freeze-Dried Bone Allograft (DFDBA) can enhance the treatment of intrabony defects, more long-term studies are needed to understand the sustained benefits and potential risks fully. These studies would help in refining treatment protocols and ensuring optimal patient outcomes over an extended period. The long-term outlook is significant because it addresses whether the regenerative effects are maintained and if there are any adverse effects that might emerge over time. Further research is essential to validate these combined therapies and their long-term impact on periodontal health.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.